Assignment Usm Mgmt

TABLE OF CONTENTS



1. Organization Profile

1.1 A brief profile of the organization


2. What is SWOT analysis

2.1 SWOT analysis explanation, benefit and shortcoming


3. Summary of the SWOT analysis


4. Elaboration on the SWOT identified

5. Recommendation or suggestion to improve the organization
























ORGANIZATION PROFILE

Pharmaniaga Berhad, a member of the Boustead Group of Companies and the largest
integrated local healthcare company in Malaysia. We are public listed company on the
main market of the Bursa Malaysia Securities Berhad with a paid up capital of RM117.7
million. One of Pharmaniaga’s subsidiaries is Pharmaniaga Lifescience Sdn Bhd
manufacturing of generic pharmaceuticals. Specializing in fill and finish of small volume
parenteral products to International Quality Standards. With a newly constructed high
tech facility, it is fast becoming a leader in the region.


Company name: Pharmaniaga Lifescience Sdn Bhd

Address: Lot 7, Jalan PPU 3, Taman Perindustrian Puchong Utama, 47100 Puchong
Selangor Malaysia

Develop: 2008

Number of employee: 65

Manufacture: Small Volume Parenteral Products



VISION
The preferred pharmaceutical brand in regional markets.
MISSION
Provide quality products and superior services by professional, committed and caring
employees.




Definition of SWOT Analysis

It is a tool to identify the Strengths, Weakness, Opportunities and Threats of an organization.
Specifically, SWOT is a basic straightforward model that assesses what an organization can
and cannot do as well as its potential opportunities and threats. The method of SWOT analysis
is to take the information from an environmental analysis and separate it into internal (strengths
and weakness) and external issues (opportunities and threats). Once this completed, SWOT
analysis determines what may assist the organization in accomplishing its objectives, and what
obstacles must be overcome or minimized to achieve desired results.

Benefit of SWOT analysis

 The main advantages of conducting a SWOT analysis are that it has little or no cost
needed. Anyone who understands the business can perform a SWOT analysis.

 We can also use SWOT analysis when we don’t have much time to address a complex
situation.

 Another benefit of SWOT analysis is, we will concentrate on the most important factors
affecting our business.

 By using SWOT analysis we can;

Understand our business better
Address weakness
Capitalize on opportunities
Take advantage of our strength
Develop business goals and strategies for achieve
Cost saving

Shortcoming of SWOT Analysis

 The analysis does not provide a means to identify the significance of one item versus
another within a list or different items in the separate lists.

 This type of analysis requires amount of time and energy when used in a large
organization.

 The analysis considers data that is available at a particular moment and may become
outdated quickly.

 People can generate list blindness, but the list alone will not help to realize the
organizations goals. They need to move beyond the analysis list and discuss what
activities would help to achieve their objectives.




SUMMARY OF THE SWOT ANALYSIS








































STRENGTHS

US FDA & EU GMP designed facility
Ample space for expansion
Government Link Company
EU GMP compliance
Top niche European equipment
WEAKNESSES

Differentiation against competitors is a real challenge for existing product
Existing product are classified as service items
Capabilities are limited to liquids SVIs
Low volume and low margin products
Barrier to investment due to current scenario
OPPORTUNITIES

EU GMP certification is opening the doors of international business
Existing site can tap into low volume & high margin product
First mover advantages for in-demand technologies e.g.FD, PFS & Penfills
OE initiatives to reduce COGS
Contract manufacturing for private market
THREATS
Competition from local & regional generic players in Malaysia
High dependence on government tenders
Non profitable business model
Limited business opportunity due to lack of versatility
High cost of investment and long gestation periods to acquire new
technology
Brief Elaboration on Strength, Weakness, Opportunities and Threats Identified.
1. Strength
Pharmaniaga has a bright future by having US FDA & EU designed facility. The
facility is world class and this is the first plant in Malaysia holding EU GMP
certificate. This will attract more international investors and partners to joint
venture together with Pharmaniaga to produce more and enter an international
markets and will get all kind of support from government because they are GLC
company.
2. Weakness
Pharmaniaga is producing a generic product which other competitor already
produced. Existing products are classified as service item to all the government
Hospital in Malaysia. Although they have a high tech facilities and all but the
capabilities is limited to SVI liquids only which is a very low margin products and
not making profit.
3. Opportunities
Pharmaniaga has a vast opportunity to enter an International markets. GLC
status will help a lot to concur fully Malaysia markets. Will open more vacancy for
graduates.
4. Threats
Pharmaniaga has many competitors from local and regional generic players in
Malaysia. Highly depends on government tender is risky.









Recommendations or Suggestion to the Managing Director to Improve the
Organization